---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-021514"
form_type: "8-K"
ticker: "FORA"
cik: "0001829280"
company_name: "Forian Inc."
filed_at: "2026-05-15T13:28:10+00:00"
generated_at: "2026-05-15T13:29:51.937893+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Forian completes acquisition by 2025 Acquisition Company at $2.17/share; to delist from Nasdaq

## Summary
- 6,444,415 shares validly tendered; together with Buyer Parties' 21,991,929 shares, ~91% of outstanding shares.
- Shareholders (other than Buyer Parties) received $2.17 per share in cash; no interest, less withholding.
- Following tender acceptance, Merger Sub merged into Forian; company becomes wholly owned subsidiary of Parent.
- All directors except Max Wygod resigned; Max Wygod remains sole director of surviving corporation.
- Forian requested Nasdaq delisting and intends to file Form 15 to suspend SEC reporting obligations.

## SEC filing metadata
- accession: 0001140361-26-021514
- form_type: 8-K
- ticker: FORA
- cik: 0001829280
- company_name: Forian Inc.
- filed_at: 2026-05-15T13:28:10+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/ef20073626_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-021514
- JSON: https://secwatch.observer/filing/0001140361-26-021514.json
- Plain text: https://secwatch.observer/filing/0001140361-26-021514.txt

## Key facts
- Executive change
  Ian G. Banwell resigned as director at Forian Inc..
  - Action: resigned
  - Role: director
  source text: At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm
- Executive change
  Kristiina Vuori, M.D., Ph.D. resigned as director at Forian Inc..
  - Action: resigned
  - Role: director
  source text: At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm
- Executive change
  Mark J. Adler, M.D. resigned as director at Forian Inc..
  - Action: resigned
  - Role: director
  source text: At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm
- Executive change
  Jennifer Hajj resigned as director at Forian Inc..
  - Action: resigned
  - Role: director
  source text: At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm
- Executive change
  Adam Dublin resigned as director at Forian Inc..
  - Action: resigned
  - Role: director
  source text: At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm
- Executive change
  Alyssa Varadhan resigned as director at Forian Inc..
  - Action: resigned
  - Role: director
  source text: At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm
- Executive change
  Shahir Kassam-Adams resigned as director at Forian Inc..
  - Action: resigned
  - Role: director
  source text: At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm
- Governance Changes
  Forian Inc.: Bylaws amended and restated in their entirety (effective 2026-05-15).
  - Change: bylaw amendment
  - Effective: 2026-05-15
  source text: on May 15, 2026, the Company’s articles of incorporation and bylaws were each amended and restated in their entirety
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm
- Governance Changes
  Forian Inc.: Articles of incorporation amended and restated in their entirety (effective 2026-05-15).
  - Change: charter amendment
  - Effective: 2026-05-15
  source text: on May 15, 2026, the Company’s articles of incorporation and bylaws were each amended and restated in their entirety
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm
- M&A Transactions
  Forian Inc. underwent a change of control involving 2025 Acquisition Company, LLC for $2.17 per share in cash (closed 2026-05-15).
  - Action: change of control
  - Counterparty: 2025 Acquisition Company, LLC
  - Consideration: $2.17 per share in cash
  - Closing: 2026-05-15
  source text: the “ Offer ”) to acquire any and all of the issued and outstanding shares of common stock, par value $0.0001 per share of the Company (the “ Shares ”), at a purchase price of $2.17 per Share, in cash, without interest thereon and less any applicable tax withholding (the “ Offer Price ”). The Offer and related withdrawal rights expired as scheduled one
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829280/000114036126021514/0001140361-26-021514-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.